UMTB Biomedical

UMTB Biomedical, a subsidiary of Vivex Biologics, is a prominent regenerative medicine company that operates the University of Miami Tissue Bank, the oldest tissue bank in the United States. The company specializes in the processing and distribution of high-quality allografts and biological products designed for orthopedic, spinal, and wound care applications. Their flagship products include VIA Disc, a non-surgical cellular allograft for degenerative disc disease, and OsteoAMP, a bone graft substitute rich in endogenous growth factors. UMTB Biomedical leverages a long-standing partnership with the University of Miami to integrate academic research with advanced manufacturing capabilities. The company is dedicated to improving patient outcomes through innovative tissue-engineered solutions and rigorous quality standards. With a focus on the musculoskeletal and wound care markets, UMTB Biomedical remains a key player in the biologics industry.